
TRAIN SRL
TRAIN SRL
1 Projects, page 1 of 1
Open Access Mandate for Publications and Research data assignment_turned_in Project2024 - 2029Partners:VHIO, PFIZER INC, INFORMATION TECHNOLOGY FOR TRANSLATIONAL MEDICINE (ITTM) SA, HUS, GE +40 partnersVHIO,PFIZER INC,INFORMATION TECHNOLOGY FOR TRANSLATIONAL MEDICINE (ITTM) SA,HUS,GE,PATVOCATES GMBH,BMS,HUMANITAS MIRASOLE SPA,GATES VENTURES LLC,EMBL,DNV,UNIBO,PATVOCATES GMBH,University of Vienna,Charité - University Medicine Berlin,DNV,HULAFE,HULAFE,Janssen (Belgium),PFIZER INC,VHIR,INFORMATION TECHNOLOGY FOR TRANSLATIONAL MEDICINE (ITTM) SA,TRAIN SRL,CENTRE FOR RESEARCH AND TECHNOLOGY HELLAS CERTH,VHIR,BMS,HUS,CERTH,European Alliance for Personalised Medicine,Novo Nordisk,Janssen (Belgium),FHG,GATES VENTURES LLC,UPM,MATICAL INNOVATION SL,Novo Nordisk,MATICAL INNOVATION SL,VHIO,i-HD,TRAIN SRL,HUMANITAS MIRASOLE SPA,ERASMUS MC,LUMC,BSC,European Alliance for Personalised MedicineFunder: European Commission Project Code: 101172872Overall Budget: 22,415,500 EURFunder Contribution: 12,438,800 EURSYNTHIA is an ambitious collaboration between public and private institutions to facilitate the responsible use of Synthetic Data (SD) in healthcare applications. The project will improve the methodological and technical aspects of SD Generation (SDG) by developing new techniques and advancing established ones for different data modalities, including genomics and imaging, to improve the generation of realistic multimodal and longitudinal data. This project will provide the research community with approaches for transparent benchmarking of alternative SDG methods for specific applications, identify and establish evaluation metrics and methodologies, and contribute to the standardisation of an evaluation assessment framework for SD. Robust evidence of SD applicability in a set of use cases across a broad spectrum of medical conditions will be crucial to demonstrate the potential of SD to accelerate data-driven solutions of equivalent quality to those derived from real patient data. Furthermore, legal and regulatory implications of SD use will be analysed with the aim of delivering an assurance framework to guide secure SD utilization in healthcare. These significant breakthroughs will be implemented through the open SYNTHIA federated platform, facilitating responsible SD use by the health research community. The platform will facilitate users´ long-term access to extensively validated, reusable synthetic datasets, as well as to SDG workflows and SD assessment frameworks. The federated infrastructure will rely on extended open-source frameworks for interoperability with other data-sharing infrastructures in the context of the European Health Data Space. A multidisciplinary collaboration of SDG developers, FAIR data experts, clinical researchers, developers of therapies and data-based tools, legal experts, socio-economic analysts, regulatory, policy advocacy, and communication experts will provide a 360º vision on how to advance healthcare applications through SD use.
more_vert